본문으로 건너뛰기
← 뒤로

A case report of semaglutide induced sarcopenia: causes of fatigue in older adults.

증례보고 1/5 보강
Korean journal of family medicine 2025 Vol.46(4) p. 288-291
Retraction 확인
출처

PICO 자동 추출 (휴리스틱, conf 2/4)

유사 논문
P · Population 대상 환자/모집단
환자: type 2 diabetes and dyslipidemia presented with progressive fatigue over 2 years
I · Intervention 중재 / 시술
추출되지 않음
C · Comparison 대조 / 비교
추출되지 않음
O · Outcome 결과 / 결론
The patient's fatigue improved after reducing the semaglutide dose and implementing a tailored exercise program that focused on muscle strengthening. This case highlights the potential contribution of semaglutide to muscle mass loss and subsequent fatigue, particularly among older adults.

Mohamad AA

📝 환자 설명용 한 줄

Semaglutide, a medication used for type 2 diabetes and weight loss, may have unexpected side effects such as sarcopenia and age-related loss of muscle mass and strength.

이 논문을 인용하기

↓ .bib ↓ .ris
APA Mohamad AA (2025). A case report of semaglutide induced sarcopenia: causes of fatigue in older adults.. Korean journal of family medicine, 46(4), 288-291. https://doi.org/10.4082/kjfm.25.0008
MLA Mohamad AA. "A case report of semaglutide induced sarcopenia: causes of fatigue in older adults.." Korean journal of family medicine, vol. 46, no. 4, 2025, pp. 288-291.
PMID 40223309 ↗

Abstract

Semaglutide, a medication used for type 2 diabetes and weight loss, may have unexpected side effects such as sarcopenia and age-related loss of muscle mass and strength. A 74-year-old male patient with type 2 diabetes and dyslipidemia presented with progressive fatigue over 2 years. He experienced a significant decline in walking endurance and speed despite the absence of joint pain or other obvious causes. He had a history of ocular myasthenia gravis and localized prostate cancer, both of which were well-managed. Further investigation revealed a weight loss of 8 kg after starting semaglutide treatment for diabetes. Physical examinations revealed reduced muscle bulk and strength. Extensive investigations, including blood tests, imaging, and cardiopulmonary exercise testing, have ruled out other potential causes of fatigue. The patient's fatigue improved after reducing the semaglutide dose and implementing a tailored exercise program that focused on muscle strengthening. This case highlights the potential contribution of semaglutide to muscle mass loss and subsequent fatigue, particularly among older adults.

🏷️ 키워드 / MeSH 📖 같은 키워드 OA만

🏷️ 같은 키워드 · 무료전문 — 이 논문 MeSH/keyword 기반

🟢 PMC 전문 열기